3D In Vitro Models of Mammalian Aging (R21, No Clinical Trial)
This R21 funding opportunity supports exploratory, interdisciplinary projects to create complex 3D mammalian microphysiological systems (MPS) — such as tissue chips or organoids — that model aging processes seen in whole organisms. The NOFO prioritizes human cell–derived systems (nonhuman mammalian cells allowed for validation) and aims to accelerate use of MPS in aging biology and drug discov…
This notice of funding opportunity (NOFO) invites applications that propose interdisciplinary research that aims to develop complex mammalian 3-dimensional (3D)in vitromicrophysiological systems (MPS) to model aging and recapitulate aging processes/phenotypes observed in the whole organismin viv…
Funding Source
Eligibility
Other Eligible Applicants include the following: Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; U.S. Territory or Possession; Non-domestic (non-U.S.) E…
Supporting links
Documents
Secure Grant Funding 10x Faster
Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.
Already have an account? Sign In
Trusted by 500+ Happy Customers